Test 1 Flashcards
The study of intrinsic sensitivity or responsiveness of the body to a drug and the mechanisms by which it occurs. What drug does to body. Effect site concentration and clinical effect
Pharmacodynamics
Study of absorption, distribution, metabolism (biotransformation), and excretion of a drug. What body does to a drug.
Pharmacokinetics
A protein or other substance that bind to an endogenous chemical or drug
Receptor
Properties of receptors
Sensitivity
Selectivity
Specificity
Receptor Sensitivity
Responsiveness or reactivity of a receptor to a particular ligand or substance
Receptor Selectivity
Preference of a ligand for a specific type of subtype of receptor
Receptor Specificity
The degree to which a receptor recognizes and binds to a particular ligand over other substances
Drug receptor classification
Generic characterization, similarity of structure and function
Examples of receptor classifications
G protein coupled, ligand gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters, enzymes
Receptor locations
Lipid bilayer of cell membrane
Intracellular proteins
Circulating proteins
Also there are drugs that do not interact with proteins at all
One of many mechanisms that contribute to variability in drug response
Changing number of receptors aka upregulation or downregulation
Signal transduction
Process by which a cell converts one kind of signal or stimulus into another
Ordered sequences or cascades of biochemical reactions inside the cell
ex. second messenger pathways
Drug response equation
Drug + Receptor⇆ (Drug Receptor Complex)⇄ Tissue Response
Fundamental to pharmalogic principles and derived from the law of mass action
Affinity and Efficacy
Describe the degree of drug receptor interaction for a given drug and receptor protein population
Affinity
Potency. Strength of binding to receptors. Weak affinity can be bumped off by something with strong affinity. Ex Aspirin has STRONG affinity
Efficacy
The ability of a drug to produce the desired effect or maximum response. The magnitude of a response with respect to a given dose. (dilaudid vs. morphine)
Pure antagonists
Have receptor affinity BUT lack intrinsic efficacy or activity. Similar in structure to corresponding agonist.
Competitive antagonists
Have a weak affinity for the same receptor protein and may be displaced by an agonist
Ex. Atropine and esmolol
Noncompetitive antagonists
Have a strong affinity for the receptor protein and cannot be displaced by the agonist
Ex. Aspirin
Agonist Antagonist
Second major type of antagonist drugs. Have receptor protein affinity and intrinsic activity, but often only a fraction of the potency of the full agonist.
Ex. Nalbuphine
Physiological antagonism
two AGONIST drugs that bind to different receptors. Both drugs bind to specific unrelated receptor proteins, initiate a protein conformational shift, illicit individual tissue responses. Responses generate opposing forces.
Ex. Isopreteronol vasodilation and NE induced vasoconstriction. Net effect is less than if either drug were used alone.
Chemical antagonism
When a drug’s action is blocked and no receptor activity is involved.
Ex. protamine forms an ionic bond with heparin and renders it inactive
Full agonist
Binds to a receptor site and turns on response, mimics endogenous ligand, produces maximal effect.
Ex. Dopamine, propofol
Down regulation is continued stimulation of cells with
AGONISTS. Results in states of desensitization. The effects of same amounts of drug are diminished (because now there’s not as many receptors) and more drug is required.
Up-regulation happens with chronic administration of
ANTAGONISTS. The number and sensitivity of the receptors increases as response to chronic blockade. Pt develops tolerance and requires higher doses of antagonists.
Drug interaction
Alteration in the therapeutic action of a drug by concurrent administration of another drug or substance
Types of drug interaction
Addition
Synergism
Potentiation
Antagonism
Addition
1+1=2
Synergism
1+1=3
Potentiation
1+0=3
Antagonism
1+1=0
The drug interaction between most anesthetics is
Syngergism
Properties influencing pharmacokinetics
Molecular size
Transporters
Lipid solubility and degree of ionization
Ion trapping
Protein binding
Molecular Size
The smaller the agent, the easier it crosses lipid membranes and membranes of tissues
Transporters
Control entry and exit molecules. Can affect bioavailability, clearance, volume of distribution, and half life for orally dosed drugs
Drive their substrates out of the cell
Efflux transporters.
Transfer their substrates into cells
Uptake transporters
Water soluble form of a drug
Ionized (charged).
Not absorbed well orally and not metabolized by the liver.
Excreted via the renal system.
Lipid soluble form of drug
Nonionized (uncharged)
Able to cross membranes easily.
Cannot be excreted by the kidneys so it gets reabsorbed for metabolism by the liver.
Degree of ionization is determined by
the dissociated constant or pKa
pH of surrounding fluid